The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.
about
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsLectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.Determination of true ratios of different N-glycan structures in electrospray ionization mass spectrometry.Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.Acute-phase glycoprotein N-glycome of ovarian cancer patients analyzed by CE-LIF.The effect of blood sampling and preanalytical processing on human N-glycome
P2860
The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The serum glycome to discrimin ...... r and benign ovarian diseases.
@ast
The serum glycome to discrimin ...... r and benign ovarian diseases.
@en
The serum glycome to discrimin ...... r and benign ovarian diseases.
@nl
type
label
The serum glycome to discrimin ...... r and benign ovarian diseases.
@ast
The serum glycome to discrimin ...... r and benign ovarian diseases.
@en
The serum glycome to discrimin ...... r and benign ovarian diseases.
@nl
prefLabel
The serum glycome to discrimin ...... r and benign ovarian diseases.
@ast
The serum glycome to discrimin ...... r and benign ovarian diseases.
@en
The serum glycome to discrimin ...... r and benign ovarian diseases.
@nl
P2093
P2860
P356
P1433
P1476
The serum glycome to discrimin ...... r and benign ovarian diseases.
@en
P2093
Elena Iona Braicu
Karina Biskup
Rudolf Tauber
Véronique Blanchard
P2860
P304
P356
10.1155/2014/238197
P577
2014-08-12T00:00:00Z